Enabling Sites for Outcomes
Sponsored by: Teckro
- Clinical Trials
Date: 14 September
Days to go: 93
Time: 4PM London/5PM CET
Fundamental Principles for Today’s Clinical Trials
In the last year, clinical trial operations were forced to welcome alternative technological approaches to alleviate disruptions from the global pandemic. With the dust settled a bit and a taste of the increased efficiency and visibility offered by these approaches, many are considering how to leverage this momentum to optimize use of technology beyond disruption management. But the question is how can all study stakeholders - patients, sponsors, investigators and staff - benefit from the efficiency, transparency, and visibility that technology offers?
This session is designed to equip senior leadership in clinical operations with a framework to select and evaluate innovation and manage change to optimize clinical trials not only for today but with lasting effect for the future. Rather than reviewing tactical decisions about point solutions, this session will give you tips and insights from key trial stakeholders on how to ensure your evaluation of technology starts with the end in mind and supports faster, safer, more efficient clinical trials.
Global Head of Strategy
Malia Lewin is global head of strategy, ensuring both clinical and market fit for Teckro products. An attorney by training, Malia Lewin has over 20 years of experience in the life sciences industry. Passionate about getting life-changing healthcare innovations to patients, Malia has worked on behalf of non-profit organizations, pharmaceutical and biotechnology companies, hospital systems, and technology companies to expedite the path of scientific discoveries from bench to clinic.
Lydia Beaudette (MSc),
Manager of Growth & Strategic Partnerships
Lydia Beaudette (MSc) has been working at the Site level in the Clinical Research industry for 7 years, currently working as the manager of growth & strategic partnerships at LMC Manna Research. Here, she focuses on new site initiations & acquisitions, as well as strategic company projects, such as new technology adoption. Lydia serves as a board member of the ACRP Canadian Chapter and maintains both CCRC and ACRP-PM certification. She is currently working towards her MBA.
Key Learning Objectives
- How to select and evaluate technology to support faster, safer, and more efficient clinical trials
- How to leverage digital solutions to support guiding principles for effective clinical trials
- How to incorporate insights from clinical investigators and staff to advance clinical operations
- Clinical Operations Leader
- Clinical Innovation Leader
- Global Clinical Development Director
- Global Operations Program Leader
- Global Studies Leader
- Global Trial Director
- Head of Site Management
- VP Digital Development
- VP Clinical Operations
- Chief Medical Officer